Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

ParacetamolAlso known as acetaminophen

Common medicine part of whose effect is attributed, in rodents, to AM404, a brain metabolite acting on TRPV1.

Level of detail

C₈H₉NO₂

CAS 103-90-2

Family
ECS pharmacological toolOther target
Molar mass
151.16 g/mol

Updated on

In plain terms

Paracetamol is a common medicine for pain and fever, available without a prescription. Its mechanism was long poorly understood. In mice and rats, part of its effect goes through a compound made in the brain, AM404, which resembles the cannabinoids produced by the body. It is not a cannabinoid: it is an ordinary medicine from which the body makes, in small part, a related molecule.

Receptors and activity

Target network

TRPV1Agonistindirect effect: the metabolite AM404 is a potent TRPV1 agonist; paracetamol is not itself the ligand; the effect of 4-aminophenol is abolished in TRPV1-deficient mice (Högestätt et al. 2005; Barrière et al. 2013)
  • Activates
  • Binds or modulates

The lower the cited value, the closer the target sits to Paracetamol: one ring per factor of 100. A target with no measured value stays on the edge.

Where these targets live

Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of Paracetamol.

Brain, side view
Body, front view
Blood

TRPV1TRPV1 found in 7 regions of the body

  1. Sensory gangliapresentExpressed in dorsal root ganglia1
  2. Spinal cordpresentNerve fibres in the spinal dorsal horn2
  3. CortexpresentParietal cortex neurons (layers 3 and 5)3
  4. SkinpresentWidely distributed in the skin4
  5. Blood vesselspresentPresent on dermal blood vessels4
  6. BonepresentPresent on osteoclasts5
  7. LiverpresentRNA enriched in the liver6

Cited values

  1. TRPV1Agonistno measured value cited

    indirect effect: the metabolite AM404 is a potent TRPV1 agonist; paracetamol is not itself the ligand; the effect of 4-aminophenol is abolished in TRPV1-deficient mice (Högestätt et al. 2005; Barrière et al. 2013)

  2. FAAHModulatorno measured value cited

    enzyme not inhibited but required for AM404 formation (conjugation of 4-aminophenol to arachidonic acid); absent in FAAH-deficient mice (Högestätt et al. 2005)

  3. CB1Modulatorno measured value cited

    no direct binding reported; the antinociceptive effect of 4-aminophenol in the rat is prevented by a CB1 antagonist (Barrière et al. 2013)

Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

Measured effects

Not characterised. No placebo-controlled human trial has measured the effects of Paracetamol, so no level is shown.

Levels computed from placebo-controlled human trials: difference from placebo on 100, at the dose and route stated. Read the method

Pharmacology

Paracetamol occupies an unexpected place in an encyclopaedia of cannabinoids. An analgesic and antipyretic used as a medicine, it is not itself a cannabinoid; what links it here is its metabolism. In 2005, Högestätt and colleagues (Lund University) showed that after deacetylation to the primary amine, it is conjugated with arachidonic acid in the brain and spinal cord to form AM404, a potent TRPV1 agonist: the reaction depends on FAAH, the enzyme that usually breaks down anandamide, and it is absent in mice lacking this enzyme. AM404 also inhibits purified COX-1 and COX-2 and acts on the endogenous cannabinoid system (Högestätt et al. 2005). In 2013, Barrière and colleagues studied 4-aminophenol, the deacetylated metabolite of paracetamol: in mice, its antinociceptive effect and the formation of AM404 depend on FAAH, and its effect depends on TRPV1; in rats, it is prevented by blocking CB1, spinal 5-HT3 or 5-HT1A receptors, or by deleting bulbospinal serotonergic pathways. As the profile is identical to that reported for paracetamol, the authors propose that this metabolite contributes to the drug's analgesic activity through bulbospinal pathways (Barrière et al. 2013). This is a mechanistic hypothesis established in rodents, not a demonstration in humans.

History

Source
Synthetic molecule, manufactured industrially as a medicinal active ingredient. It is not of cannabis origin and does not belong to the phytocannabinoids: it appears here because, in rodents, part of its antinociceptive effect is attributed to a metabolite that acts on TRPV1 and on the endogenous cannabinoid system (Högestätt et al. 2005; Barrière et al. 2013).

Origin

Research tool

Synthetic molecule, described here by class: a simple aromatic amide, N-(4-hydroxyphenyl)acetamide, that is, a phenol ring bearing an acetamide group in the para position. Its transformation in the body is the notable point: after deacetylation to the primary amine (4-aminophenol), this is conjugated with arachidonic acid, by a FAAH-dependent reaction, to form AM404 in the brain and spinal cord (Högestätt et al. 2005).

Classification

Family, origin and source verification

Family

ECS pharmacological tool › Other target

Verification

Classification, sources and binding values checked on 20 October 2026; text read against its sources and Wikipedia.

Wikipedia (English)

Paracetamol (new tab)

Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.

References

Identifiers

Names

Common name
Paracetamol (acetaminophen)
IUPAC name
N-(4-hydroxyphenyl)acetamide
Other names
Acetaminophen · APAP

Identifiers

Formula
C₈H₉NO₂
CAS
103-90-2
PubChem CID
1983(new tab)
InChIKey
RZVAJINKPMORJF-UHFFFAOYSA-N
SMILES
CC(=O)NC1=CC=C(C=C1)O

Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.